Naowarat SaralambaSupatchara NakeesathitMayfong MayxayNewton, Paul N.Lyda OsorioKim, Jung‑RyongWhite, Nicholas J.Day, Nicholas P. J.Dondorp, Arjen M.Mallika ImwongMahidol University. Faculty of Tropical Medicine. Department of Molecular Tropical Medicine and Genetics2017-11-162017-11-162017-11-162016Malaria Journal. Vol.15, (2016), 484https://repository.li.mahidol.ac.th/handle/20.500.14594/3160Background: Non-synonymous mutations in dhfr and dhps genes in Plasmodium vivax are associated with sulfadoxine– pyrimethamine (SP) resistance. The present study aimed to assess the prevalence of point mutations in P. vivax dhfr (pvdhfr) and P. vivax dhps (pvdhps) genes in three countries: Lao PDR, India and Colombia. Methods: Samples from 203 microscopically diagnosed vivax malaria were collected from the three countries. Five codons at positions 13, 57, 58, 61, and 117 of pvdhfr and two codons at positions 383 and 553 of pvdhps were examined by polymerase chain reaction-restriction fragment length polymorphism methodology. Results: The largest number of 58R/117 N double mutations in pvdhfr was observed in Colombia (94.3 %), while the corresponding wild-type amino acids were found at high frequencies in Lao PDR during 2001–2004 (57.8 %). Size polymorphism analysis of the tandem repeats within pvdhfr revealed that 74.3 % of all the isolates carried the type B variant. Eighty-nine per cent of all the isolates examined carried wild-type pvdhps A383 and A553. Conclusions: Although SP is not generally used to treat P. vivax infections, mutations in dhfr and dhps that confer antifolate resistance in P. vivax are common. The data strongly suggest that, when used primarily to treat falciparum malaria, SP can exert a substantial selective pressure on P. vivax populations, and this can lead to point mutations in dhfr and dhps. Accurate data on the global geographic distribution of dhfr and dhps genotypes should help to inform anti-malarial drug-use policies.engMahidol UniversityOpen Access articlePlasmodium vivaxSulfadoxine–pyrimethaminedhfrdhpsResearch ArticleBioMed Central10.1186/s12936-016-1543-8